Drug recall
Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced
FDA recall event 93994 · Class III · Rhode Island Blood Center, A Division of New York Blood Center, Inc.
Key facts
| Event ID | 93994 |
|---|---|
| Recall numbers | B-0146-2024 |
| Recalling firm | Rhode Island Blood Center, A Division of New York Blood Center, Inc. |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Leukoreduced Apheresis Platelets, Pathogen Reduced, not manufactured according to specifications, was distributed. |
| Initiation date | Dec 12, 2023 |
| Report date | Mar 20, 2024 |
| Termination date | Mar 11, 2024 |
| City | Providence |
| State | RI |
| Country | United States |
| FEI number | 1270007 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: